PV
Pablo V.Verified purchase
Your cart is empty
Add prompt packs to continue
Copy, paste and use them in your favorite AI:
Just $0.08 per prompt · one-time payment
100 resources included
This collection represents the gold standard in prompt engineering for the biochemical sector, meticulously designed to transform productivity in research laboratories and high-demand industrial environments. Each tool has been structured following advanced instructional design principles, allowing professionals to automate the generation of technical documentation, streamline the analysis of complex data and strengthen the scientific rigor of their international publications. By integrating this ecosystem of prompts into their workflow, the modern biochemist dramatically reduces time spent on redundant administrative and technical writing tasks. From the optimization of purification protocols to the validation of analytical methods under international regulations, this collection offers an unprecedented competitive advantage to lead biotechnological innovation projects with technical precision and documentary excellence.
He acts as a Senior expert in Biotechnological Quality Control and Mammalian Cell Culture with over 20 years of experience in the identification of cryptic contaminants. Your objective is to design a comprehensive monitoring, detection and eradication strategy for suspected mycoplasma contamination in the cell line [Cell Line Name], which has recently shown [Describe detected abnormality: e.g. growth slowing, changes in transfection efficiency or atypical morphology]. Since mycoplasmas lack a cell wall and do not generate the characteristic turbidity of bacteria or yeasts, I need you to delve into the interference that these species (specifically M. hyorhinis, M. orale and A. laidlawii) exert on cellular metabolism, gene expression and the integrity of the experimental results in our laboratory at [Name of Research Center]. The analysis must consider why visual methods fail and why it is imperative to implement a screening system based on biological risk. Develop a detailed comparative protocol evaluating three detection methodologies: 1) Nested PCR or qPCR targeting 16S ribosomal RNA, 2) Biochemical assays of enzymatic activity (such as detection of acetate kinase or carbamate kinase), and 3) Fluorescent staining of DNA with Hoechst or DAPI under high-resolution microscopy. For each method, detail the necessary positive and negative controls, the expected limit of detection (LOD), and possible false positives resulting from [Mention specific reagent or condition]. Finally, it provides contingency guidance in the event of a positive result. It includes steps for immediate quarantine, the elimination of contaminated stocks and, in exceptional cases where the cell line is irreplaceable, a pharmacological rescue protocol using agents such as [Mention specific antibiotics such as BM-Cyclin, MRA or Plasmocin], specifying the toxicity curves that we must perform so as not to compromise long-term cell viability. If any key information needed to fill the bracketed fields is missing, ask me the necessary questions before answering.
Instant access after purchase from your dashboard. Just copy and paste into your AI.
ChatGPT, Claude, Gemini, DeepSeek, Grok, Qwen and any AI chat.
Yes. Every prompt includes bracketed fields where you insert your own information, context and specifics, so they fit your situation, country or industry.
Yes. Above you can read full sample prompts, exactly as you'll receive them, to check the quality before paying.
Yes. Pay once and they're yours forever, updates included.
Acts as a senior expert in Pharmaceutical Microbiology and Quality Control, specialized in compliance with international regulations such as USP <81> and EP 2.7.2. Your fundamental task is to design, document and validate an exhaustive technical protocol for the 'Microbiological antibiotic potency assessment' of the active ingredient [ANTIBIOTIC NAME] in its [PHARMACEUTICAL FORM] presentation. This assay is critical to ensure that the biological activity of the drug matches its label claim, using comparative methods against international or national reference standards. The protocol must begin with the characterization of the biological system. It precisely defines the required test microorganism (e.g. [ATCC/NCIMB SPECIFIC STRAIN]), detailing the maintenance conditions, the preparation of the standardized inoculum and the optical density necessary to ensure a reproducible response. Describe the selected culture medium (e.g. Antibiotic Medium No. 1), justifying its choice based on the optimal pH and the diffusion of the antibiotic in the agar matrix or its growth in liquid medium. Meticulously develop the operating procedure using the [METHOD: DIFFUSION IN AGAR / TURBIDIMETRIC]. If you choose diffusion, detail the plate design (e.g. 100 mm or 300 mm plates), the number of reservoirs or cylinders per plate and the exact volume of [VOLUME IN MICROLITRES] of the standard and sample dilutions. If you select the turbidimetric method, specify the incubation intervals in a water bath at [TEMPERATURE °C] and the use of the spectrophotometer at a wavelength of [WAVELENGTH] nm, including sterility controls and reagent blanks. Establishes the statistical design of the trial (e.g. 5-dose design for standard curve or 2+2/3+3 design for identity trials). You must include the mathematical formulas for the logarithmic transformation of doses and the calculation of relative potency using linear regression analysis. Defines the technical acceptance criteria: the correlation coefficient (r²) must be greater than [MINIMUM VALUE], and the confidence limits of [PERCENTAGE]% must be within the range of [POWER RANGE]% to [POWER RANGE]% of the estimated power. Finally, it generates a risk management and problem resolution section (Troubleshooting). Identifies potential root causes for invalid assays, such as lack of parallelism between sample and standard, zones of inhibition with fuzzy edges, or cross-contamination. Propose immediate corrective actions and a final report format that summarizes the calculated potency in [ACTIVITY UNITS/MG] and the statistical validity of the test performed for the lot [LOT NUMBER]. If any key information needed to fill the bracketed fields is missing, ask me the necessary questions before answering.
He acts as a Senior Consultant in Analytical Quality Assurance and expert in Biochemical Metrology. Your objective is to design an exhaustive technical protocol and a validation report for the study of "Enriched sample analyte recovery" applied to the [Analytic_Method_Name] method. This procedure is essential to evaluate the veracity of the method and determine if there are matrix effects that could bias the quantitative results in the determination of [Analyte_Name] within the complex matrix [Biochemical_Matrix_Type]. The protocol should begin by detailing the spiking experimental design. Describes the preparation of at least three concentration levels (low, medium and high) that cover the working range of [Expected_Concentration_Range]. It is imperative that the volume of the reference standard solution traceable to [NIST_Traceability_Standard_or_Similar] does not exceed 2% of the total sample volume to avoid excessive dilution of matrix components. You must specify the calculations necessary to determine the exact amount of mass or concentration to add, considering the purity of the standard and the density of the sample. In the data analysis section, ask for the application of the standard mathematical formula for percent recovery: %R = [(C_enriched - C_basal) / C_added] * 100. In addition to this calculation, the model must generate a statistical analysis that includes the relative standard deviation (RSD) of the replicates [Number_of_Replicas] and the 95% confidence interval. Automatically compares these values with the acceptance criteria established by the guide [AOAC_Reference_Guide_or_EMA] for the concentration level analyzed, technically justifying any observed deviation. Finally, the output must include a technical discussion section where the possible causes of an out-of-specification recovery are analyzed, such as the adsorption of the analyte on the walls of the containers, enzymatic degradation during the preparation process or the formation of insoluble complexes with [Interferent_Potential]. It concludes with a formal statement on the suitability of the method for its intended use in clinical or research trials, ensuring that the results meet the requirements of ISO 15189 or GLP as appropriate. If any key information needed to fill the bracketed fields is missing, ask me the necessary questions before answering.
It's a master instruction, optimized for AI.
Prompt
your instruction
AI
Result
Based on 6 reviews
I didn't expect them to be this complete. They're easy to adapt to my case by just changing the fields. An investment that pays for itself.
Exceeded my expectations. The prompts are really well thought out and the effort shows. One hundred percent recommended.
Delivers what it promises. The prompts are useful and practical. I recommend it.
Exactly what I was looking for. The index is organized and I find what I need instantly. Totally recommend them.
Best purchase I made this month. The prompts are really well thought out and the effort shows. Totally recommend them.
Exceeded my expectations. They saved me hours of work in the first week. Totally recommend them.